Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2009 1
2010 2
2011 2
2012 1
2013 1
2014 1
2015 1
2016 1
2017 2
2018 2
2019 4
2020 5
2021 6
2022 5
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.
Mosele F, Deluche E, Lusque A, Le Bescond L, Filleron T, Pradat Y, Ducoulombier A, Pistilli B, Bachelot T, Viret F, Levy C, Signolle N, Alfaro A, Tran DTN, Garberis IJ, Talbot H, Christodoulidis S, Vakalopoulou M, Droin N, Stourm A, Kobayashi M, Kakegawa T, Lacroix L, Saulnier P, Job B, Deloger M, Jimenez M, Mahier C, Baris V, Laplante P, Kannouche P, Marty V, Lacroix-Triki M, Diéras V, André F. Mosele F, et al. Among authors: talbot h. Nat Med. 2023 Aug;29(8):2110-2120. doi: 10.1038/s41591-023-02478-2. Epub 2023 Jul 24. Nat Med. 2023. PMID: 37488289 Free PMC article. Clinical Trial.
Bringing Interventional Radiology to Mars!
Vidal V, Boyer L, Luciani A; SFR-CNES collaborative group. Vidal V, et al. Cardiovasc Intervent Radiol. 2023 Apr;46(4):425-427. doi: 10.1007/s00270-023-03392-3. Epub 2023 Mar 14. Cardiovasc Intervent Radiol. 2023. PMID: 36918421
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer.
Decazes P, Ammari S, Belkouchi Y, Mottay L, Lawrance L, de Prévia A, Talbot H, Farhane S, Cournède PH, Marabelle A, Guisier F, Planchard D, Ibrahim T, Robert C, Barlesi F, Vera P, Lassau N. Decazes P, et al. Among authors: talbot h. J Immunother Cancer. 2023 Sep;11(9):e007315. doi: 10.1136/jitc-2023-007315. J Immunother Cancer. 2023. PMID: 37678919 Free PMC article.
Rare bioparticle detection via deep metric learning.
Luo S, Shi Y, Chin LK, Zhang Y, Wen B, Sun Y, Nguyen BTT, Chierchia G, Talbot H, Bourouina T, Jiang X, Liu AQ. Luo S, et al. Among authors: talbot h. RSC Adv. 2021 May 13;11(29):17603-17610. doi: 10.1039/d1ra02869c. eCollection 2021 May 13. RSC Adv. 2021. PMID: 35480202 Free PMC article.
Deep Learning-Based Concurrent Brain Registration and Tumor Segmentation.
Estienne T, Lerousseau M, Vakalopoulou M, Alvarez Andres E, Battistella E, Carré A, Chandra S, Christodoulidis S, Sahasrabudhe M, Sun R, Robert C, Talbot H, Paragios N, Deutsch E. Estienne T, et al. Among authors: talbot h. Front Comput Neurosci. 2020 Mar 20;14:17. doi: 10.3389/fncom.2020.00017. eCollection 2020. Front Comput Neurosci. 2020. PMID: 32265680 Free PMC article.
Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker.
Naccache R, Belkouchi Y, Lawrance L, Benatsou B, Hadchiti J, Cournede PH, Ammari S, Talbot H, Lassau N. Naccache R, et al. Among authors: talbot h. Cancers (Basel). 2022 Mar 4;14(5):1337. doi: 10.3390/cancers14051337. Cancers (Basel). 2022. PMID: 35267645 Free PMC article.
Synthetic MR image generation of macrotrabecular-massive hepatocellular carcinoma using generative adversarial networks.
Couteaux V, Zhang C, Mulé S, Milot L, Valette PJ, Raynaud C, Vlachomitrou AS, Ciofolo-Veit C, Lawrance L, Belkouchi Y, Vilgrain V, Lewin M, Trillaud H, Hoeffel C, Laurent V, Ammari S, Morand E, Faucoz O, Tenenhaus A, Talbot H, Luciani A, Lassau N, Lazarus C. Couteaux V, et al. Among authors: talbot h. Diagn Interv Imaging. 2023 May;104(5):243-247. doi: 10.1016/j.diii.2023.01.003. Epub 2023 Jan 20. Diagn Interv Imaging. 2023. PMID: 36681532
39 results